CME Group Inc. (CME)
| Market Cap | 109.49B +13.3% |
| Revenue (ttm) | 6.96B +8.9% |
| Net Income | 4.40B +17.3% |
| EPS | 12.19 +18.2% |
| Shares Out | 357.93M |
| PE Ratio | 25.08 |
| Forward PE | 23.63 |
| Dividend | $11.35 (3.71%) |
| Ex-Dividend Date | Sep 9, 2026 |
| Volume | 1,452,931 |
| Open | 303.68 |
| Previous Close | 307.24 |
| Day's Range | 301.40 - 308.76 |
| 52-Week Range | 218.31 - 329.16 |
| Beta | 0.18 |
| Analysts | Buy |
| Price Target | 317.06 (+3.65%) |
| Earnings Date | Oct 21, 2026 |
About CME
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges. In additi... [Read more]
Financial Performance
In 2025, CME Group's revenue was $6.51 billion, an increase of 6.32% compared to the previous year's $6.12 billion. Earnings were $4.02 billion, an increase of 15.50%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for CME stock is "Buy." The 12-month stock price target is $317.06, which is an increase of 3.65% from the latest price.
News
CME Group Declares Quarterly Dividend
CHICAGO, Nov. 5, 2026 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a fourth-quarter dividend of $1.30 per share. The dividend is payable December 30, 202...
U.S. clears path for first regulated equity perpetual futures
A trendy crypto-native trading product that has exploded in popularity on offshore venues is expanding its foothold in the U.S.
CME Group reports October ADV of 30M contracts, up 15% y/y
CME Group (CME) reported its average daily volume reached a new October record of 30M contracts, an increase of 15% from October 2025, when the previous record was set with…
CME Group Reports Record October ADV of 30 Million Contracts, up 15% Year Over Year
Record October ADV in interest rate, equity index, energy and agricultural products U.S. Treasu ry futures and options ADV increased 48% CHICAGO, Nov. 3, 2026 /PRNewswire/ -- CME Group, the world's le...
CME Group CEO Terry Duffy: From the Trading Floor to the Future of Markets
CME Group Chairman and CEO Terry Duffy joins Market Overtime to reflect on his career, the evolution of financial markets and the future of trading. Duffy shares how he got his start on Chicago's trad...
CME Group Brazilian Real Futures Set New Daily Volume Record Following Election
Record $9 billion notional traded, eleven times the year-to-date average daily volume (ADV) as market participants turned to CME Group to manage risk around the clock CHICAGO, Oct. 27, 2026 /PRNewswir...
CME Group price target raised to $227 from $218 at BofA
BofA raised the firm’s price target on CME Group (CME) to $227 from $218 and keeps an Underperform rating on the shares. CME reported a small profit beat driven by…
CME Group price target raised to $330 from $295 at Piper Sandler
Piper Sandler raised the firm’s price target on CME Group (CME) to $330 from $295 and keeps an Overweight rating on the shares. The firm cites an overall solid beat…
CME Group price target raised to $310 from $270 at UBS
UBS raised the firm’s price target on CME Group (CME) to $310 from $270 and keeps a Neutral rating on the shares. CME delivered solid revenue growth and an EPS…
CME Group price target raised to $333 from $315 at Wells Fargo
Wells Fargo analyst Daniel Welden raised the firm’s price target on CME Group (CME) to $333 from $315 and keeps an Overweight rating on the shares. CME’s Q3 call reinforced…
CME Group upgraded to Overweight from Underweight at JPMorgan
JPMorgan upgraded CME Group (CME) to Overweight from Underweight with a price target of $367, up from $250.
CME Group price target raised to $359 from $337 at Morgan Stanley
Morgan Stanley analyst Michael Cyprys raised the firm’s price target on CME Group (CME) to $359 from $337 and keeps an Overweight rating on the shares. Record Q3 volumes reinforce…
JPMorgan double upgrades CME on ‘constructive’ rate environment
JPMorgan analyst Kenneth Worthington upgraded CME Group (CME) to Overweight from Underweight with a price target of $367, up from $250. The interest rate environment is “constructive” for CME, driving...
CME Group price target raised to $330 from $325 at Keefe Bruyette
Keefe Bruyette raised the firm’s price target on CME Group (CME) to $330 from $325 and keeps an Outperform rating on the shares.
CME Group price target raised to $321 from $281 at Barclays
Barclays analyst Benjamin Budish raised the firm’s price target on CME Group (CME) to $321 from $281 and keeps an Equal Weight rating on the shares. The company reported a…
CME CEO Terry Duffy: We're seeing a record-level of participation
Terry Duffy, CME Group CEO, joins 'Power Lunch' to discuss record Q3 revenue, the future of trading, and more.
CME Group Earnings Call Transcript: Q3 2026
Q3 revenue reached a record $1.7B, up 13%, while ADV rose 16% to a record 29.4M contracts. Adjusted EPS increased 13% to $3.02, with broad-based volume growth and more than $100B in daily customer margin savings.
CME Group Slides: Q3 2026
CME Group has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 21, 2026.
CME Group Earnings release: Q3 2026
CME Group released its Q3 2026 earnings on October 21, 2026, summarizing the period's financial results.
CME Group Quarterly report: Q3 2026
CME Group has published its Q3 2026 quarterly earnings report on October 21, 2026.
CME Group reports Q3 adjusted EPS $3.02, consensus $2.99
Reports Q3 revenue $1.74B, consensus $1.72B. “As uncertainty intensified in Q3, clients turned to CME Group (CME) in record numbers to manage risk and capitalize on opportunities,” said CME Group…
CME Group Inc. Reports Highest Q3 Revenue on Record for Q3 2026
• Double-digit revenue and net income growth CHICAGO, Oct. 21, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2026. The company reported r...
CME Group announces first trade for Bitcoin Cash and Uniswap futures
CME Group (CME) announced that FalconX and GSR have executed the first block trade in its new Bitcoin Cash and Uniswap futures. The new contracts further extend CME Group’s single-asset…
CME Group Announces First Trade for Bitcoin Cash and Uniswap Futures
CHICAGO, Oct. 20, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that FalconX and GSR have executed the first block trade in its new Bitcoin Cash (BCH) an...
CME Group Slides: Investor presentation
CME Group has posted slides in relation to its latest quarterly earnings report, which was published on October 20, 2026.